Cipla launches ‘ELIFast’ IgG ELISA test for COVID-19 antibody detection
As part of this collaborative effort, Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA